» Articles » PMID: 26261210

TRAP150 Interacts with the RNA-binding Domain of PSF and Antagonizes Splicing of Numerous PSF-target Genes in T Cells

Overview
Specialty Biochemistry
Date 2015 Aug 12
PMID 26261210
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

PSF (a.k.a. SFPQ) is a ubiquitously expressed, essential nuclear protein with important roles in DNA damage repair and RNA biogenesis. In stimulated T cells, PSF binds to and suppresses the inclusion of CD45 exon 4 in the final mRNA; however, in resting cells, TRAP150 binds PSF and prevents access to the CD45 RNA, though the mechanism for this inhibition has remained unclear. Here, we show that TRAP150 binds a region encompassing the RNA recognition motifs (RRMs) of PSF using a previously uncharacterized, 70 residue region we have termed the PSF-interacting domain (PID). TRAP150's PID directly inhibits the interaction of PSF RRMs with RNA, which is mediated through RRM2. However, interaction of PSF with TRAP150 does not appear to inhibit the dimerization of PSF with other Drosophila Behavior, Human Splicing (DBHS) proteins, which is also dependent on RRM2. Finally, we use RASL-Seq to identify ∼40 T cell splicing events sensitive to PSF knockdown, and show that for the majority of these, PSF's effect is antagonized by TRAP150. Together these data suggest a model in which TRAP150 interacts with dimeric PSF to block access of RNA to RRM2, thereby regulating the activity of PSF toward a broad set of splicing events in T cells.

Citing Articles

Disruption of pulmonary microvascular endothelial barrier by dysregulated claudin-8 and claudin-4: uncovered mechanisms in porcine reproductive and respiratory syndrome virus infection.

Sun W, Wu W, Fang X, Ge X, Zhang Y, Han J Cell Mol Life Sci. 2024; 81(1):240.

PMID: 38806818 PMC: 11133251. DOI: 10.1007/s00018-024-05282-4.


Role of RNA binding proteins of the behavior and human splicing (DBHS) family in health and cancer.

Takeiwa T, Ikeda K, Horie K, Inoue S RNA Biol. 2024; 21(1):1-17.

PMID: 38551131 PMC: 10984136. DOI: 10.1080/15476286.2024.2332855.


A novel HPV16 splicing enhancer critical for viral oncogene expression and cell immortalization.

Jonsson J, Wang L, Kajitani N, Schwartz S Nucleic Acids Res. 2023; 52(1):316-336.

PMID: 37994701 PMC: 10783526. DOI: 10.1093/nar/gkad1099.


The three as: Alternative splicing, alternative polyadenylation and their impact on apoptosis in immune function.

Blake D, Lynch K Immunol Rev. 2021; 304(1):30-50.

PMID: 34368964 PMC: 8616797. DOI: 10.1111/imr.13018.


A conserved role for the ALS-linked splicing factor SFPQ in repression of pathogenic cryptic last exons.

Gordon P, Hamid F, Makeyev E, Houart C Nat Commun. 2021; 12(1):1918.

PMID: 33771997 PMC: 7997972. DOI: 10.1038/s41467-021-22098-z.


References
1.
Lynch K, Weiss A . A model system for activation-induced alternative splicing of CD45 pre-mRNA in T cells implicates protein kinase C and Ras. Mol Cell Biol. 1999; 20(1):70-80. PMC: 85051. DOI: 10.1128/MCB.20.1.70-80.2000. View

2.
Lee K, Hsu I, Tarn W . TRAP150 activates pre-mRNA splicing and promotes nuclear mRNA degradation. Nucleic Acids Res. 2010; 38(10):3340-50. PMC: 2879504. DOI: 10.1093/nar/gkq017. View

3.
Heyd F, Lynch K . Phosphorylation-dependent regulation of PSF by GSK3 controls CD45 alternative splicing. Mol Cell. 2010; 40(1):126-37. PMC: 2954053. DOI: 10.1016/j.molcel.2010.09.013. View

4.
Melton A, Jackson J, Wang J, Lynch K . Combinatorial control of signal-induced exon repression by hnRNP L and PSF. Mol Cell Biol. 2007; 27(19):6972-84. PMC: 2099238. DOI: 10.1128/MCB.00419-07. View

5.
Duhoux F, Auger N, De Wilde S, Wittnebel S, Ameye G, Bahloula K . The t(1;9)(p34;q34) fusing ABL1 with SFPQ, a pre-mRNA processing gene, is recurrent in acute lymphoblastic leukemias. Leuk Res. 2011; 35(7):e114-7. DOI: 10.1016/j.leukres.2011.02.011. View